Proactive Investors - Run By Investors For Investors

Ilera Healthcare deal is 'one piece of the puzzle' for Zelda Therapeutics in 'globalising product'

Zelda Therapeutics Ltd (ASX:ZLD, OTCBB:ZLDAF) managing director Dr Richard Hopkins speaks to Proactive Investors about the medical cannabis researcher's binding heads of agreement (HoA) with US-based medicinal cannabis company Ilera Healthcare LLC.

The deal complements a number of agreements that Zelda has in place with international partners, and more such deals are set to be announced this year.

Hopkins  explains, "We've got access to in excess of 110,000 registered medicinal cannabis patients at the moment, which is in excess of 30 times larger than the whole Australian market; so this is our approach to globalising our product... Putting in that framework that allows us to rapidly commercialise the outcomes from our clinical trials."

Join Proactive’s Crypto, Blockchain and Cannabis Telegram group here  
View full ZLD profile View Profile

Zelda Therapeutics Ltd Timeline

Copyright ©, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use